In this use case, find out how MMIT, using NorstellaLinQ, developed a robust, unified dataset to provide comprehensive insights into a potential addressable rare disease population.
Learn how one manufacturer used integrated claims, lab, EMR and coverage data to identify newly diagnosed, early-stage cancer patients for just-in-time HCP targeting.
In this use case, learn how MMIT, powered by NorstellaLinQ, translated complex RWD into actionable strategies to help the client achieve business growth while advancing equity and patient access.
In this use case, learn how MMIT, powered by NorstellaLinQ, translated complex RWD into actionable insights which helped the client tackle affordability and access challenges in a complex therapeutic area.
In this use case, learn how MMIT Analytics enabled clinicians to easily identify covered alternatives when a drug was not approved, ensuring continuity in patient care.
In this use case, learn how the company used MMIT’s API to get access to formulary, medical policy, and restriction data, helping the client integrate this information into their existing software platform.
Learn how a small biopharma company used MMIT’s Analytics and Surveillance products to engage payers, educate providers and secure coverage for its rare disease therapy.
Learn how one national payer uses MMIT data to track market share, understand the depth and breadth of competitor offerings, and identify new opportunities for growth.
This case study details how a mid-size pharma company improved its launch dashboards with an API from MMIT.
This case study explains how one regional payer leveraged MMIT’s Fee Scheduler solution to simplify methodology review, speed claim verification and improve workflow.
This case study details how Peregrine Market Access leveraged MMIT’s Analytics and FormTrak solutions to help one pharma company spread the news about its product’s coverage to healthcare providers.
Learn how one small biopharma company achieved 95% payer coverage for its rare disease therapy using MMIT’s strategic data solutions.
Learn how one small biopharma company used MMIT’s claims, coverage and restriction data to better understand payer mix and utilization analytics in preparation for the successful launch of its oncology combination therapy.
Learn how one small pharma company used MMIT to understand how payers viewed their product and its competitors and communicate coverage changes to providers.
Learn how MMIT’s newest offering, HCP Message Monitor, helped a pharmaceutical manufacturer enhance brand messaging by evaluating HCP understanding and recall.
Learn how one pharma company leveraged MMIT’s Analytics solution, FormTrak and Coverage Search tools to drive sales impact.
Learn how one rare disease manufacturer leveraged MMIT’s Analytics solution and Payer Landscape platform to identify coverage changes and build stronger payer relationships.
Learn how one pharma company used immediate payer feedback on off-label coverage decisions to help it determine whether to seek a new FDA indication.
Learn how a manufacturer used MMIT’s custom market research to assess the value of their product in the asthma treatment space and address unmet marketplace needs.
Learn how a manufacturer used MMIT’s custom market research to find how their product would be assessed during the clinical and financial review portions of a P&T session.
Learn how a manufacturer used MMIT’s custom market research to determine how it’s viewed in the marketplace in a variety of categories across time and against analog companies.
Learn how a manufacturer used MMIT’s custom market research to inform launch pricing and access strategy for their new product.
Learn how KORU Medical Systems used claims and payer coverage data to better understand reimbursement and improve patient access to its devices.
Learn how one biopharma company prepared for a new competitor by analyzing past market analogs and sales trends.
A pharma company with several approved brands with large market share was developing a new Crohn’s disease drug. The company partnered with MMIT to determine whether the new drug would be approved in the marketplace
Learn how one biotech company used MMIT’s Analytics, Surveillance, FormTrak and Coverage Search tools to achieve its launch goals early.
Learn how a healthcare IT organization was able to gain a deeper understanding of their market potential and obtain competitive intelligence with Payer Landscape.
Learn how a P&T review helped one pharma company understand how its product would be assessed, leading to a new focus on gathering real-world evidence.
Hear from pharmaceutical companies already using Contract Validation about how the solution has changed their workflow.
How MMIT’s longstanding advisory relationship with a global pharmaceutical company helped transform its portfolio strategy.
Learn how pharma companies that were early adopters of MMIT’s FormTrak integration in Veeva CRM see the new functionality changing their workflow.
Learn how a pharma company leveraged MMIT’s Strategic Launch Report combined with In-Depth Interviews to get a unique view into the market access path for its therapy.
Learn how MMIT and MarketLauncher helped a medtech company engage a difficult-to-reach health plan audience.
Learn how RJ Health helped a niche healthcare company bolster its payer communications.
Learn how a data-driven market access strategy and competitor benchmarking led to launch excellence.
Learn how a small pharma company leveraged MMIT’s Analytics platform to drive its messaging with healthcare providers as it launched its first commercial product at the start of the COVID-19 pandemic.
Learn how a pharma company partnered with MMIT’ to understand payer perceptions of its brand over time as competitors enter the market.
Learn how a pharma company preparing for a drug launch partnered with MMIT to gain insight into the most effective messaging with payers.
Learn how a pharma company’s market access team leveraged MMIT’s quantitative online surveys to obtain a custom pricing and contracting study to support its drug launch.
Description